In February 2019, the FDA issued a letter to raise awareness of the risk for a rare type of lymphoma, BIA-ALCL, that is linked to all types of breast implants. Although this is an uncommon reaction to implants, all women who have or intend to get an implant after breast cancer should be aware of this risk. Learn more about this risk here.

“Almost anyone who is a candidate for lung surgery is generally a candidate for minimally invasive surgery,” says Richard Chang, MD, FACS. Newer types of surgery are becoming available for patients with lung cancer that has not spread to other organs.

“CAR T-cell therapy provides an exciting and additional option for patients who have failed more traditional regimens,” says Dr. Gwen Nichols, Chief Medical Officer for Leukemia & Lymphoma Society.

New therapies that are now available for people with this type of cancer have fewer side effects than traditional chemotherapy and can improve survival and quality of life.

Biomarkers are biologic markers that indicate changes in our genes and may increase the risk of cancer.

“Almost anyone who is a candidate for lung surgery is generally a candidate for minimally invasive surgery,” says Richard Chang, MD, FACS. Newer types of surgery are becoming available for patients with lung cancer that has not spread to other organs.

For the first time in 40 years, patients who are considering reconstructive surgery after a mastectomy because of breast cancer have a new option for tissue expansion—the AeroForm Tissue Expander System.

Here is an outline of what to expect when follicular lymphoma returns.

Low-dose CT screening is the only screening method recommended by the US Preventive Services Task Force for lung cancer, yet only 3.9% of eligible people are actually screened.

According to the Cancer Research Institute, only 3% to 6% of eligible patients with cancer participate in clinical trials in the United States. Read the reasons why clinical trials are a great option to consider.

Check out some of the most exciting immunotherapies that are giving hope to people fighting this disease, which is responsible for 1 in every 4 cancer-related deaths in the United States.

This article offers a summary of follicular lymphoma, a type of slow-growing non-Hodgkin lymphoma, and discusses the risk factors, symptoms, and treatment options for this disease.

Prevention is an integral part of life. Since lung cancer causes more deaths than any other type of cancer, taking steps to prevent this deadly disease should be a “no-brainer.”

The costs of cancer have always been a concern, but new studies show that this concern will affect more than just your bank account.

For patients with cancer, decision-making can feel like a full-time job. The prospect of participating in a clinical trial can become just one more decision that needs to be made. Without the proper information and resources, participating in a clinical trial is often not even an option.

Although most thyroid cancers can be cured at early stages, it is the most rapidly increasing cancer type in the United States, according to the American Cancer Society. It is not yet clear why the incidence of thyroid cancer is increasing so fast.

October is Breast Cancer Awareness Month. But for the 291,840 women who will be diagnosed with breast cancer in the United States this year, and the 2.8 million women living with a history of breast cancer, that awareness lasts all year.

An overview of leukemia with information about risk factors, common symptoms, and treatments options, including immunotherapy.

The risks for multiple myeloma, a rare and aggressive blood cancer, have long been linked to increasing age (older than 65), male sex, and African-American race. However, researchers are now looking into genetic risk factors to better understand and treat the disease.

This article is about the risk factors, symptoms, and treatment of brain cancer.

April is a head and neck cancer awareness month. Approximately 59,340 new cases of head and neck cancer will be diagnosed in 2015, according to the American Cancer Society, and 12,290 deaths from these cancers are expected this year.

Whether a child is fighting to refuse treatment or a terminally ill adult desperately wants to try an experimental drug, patients with cancer throughout the country are attempting to break barriers that keep them from making personal choices about their treatment.